Skip to main content
Evome Medical Technologies Inc. logo

Evome Medical Technologies Inc. — Investor Relations & Filings

Ticker · EVMT ISIN · CA30053H1055 TSXV Manufacturing
Open in API
Filings indexed 403 across all filing types
Latest filing 2023-04-26 Regulatory Filings
Country CA Canada
Listing TSXV EVMT

About Evome Medical Technologies Inc.

https://www.evomemedical.com

Evome Medical Technologies Inc. is a medical device enterprise dedicated to the design, development, production, and distribution of specialized medical devices. The company's core business centers on human performance and rehabilitative solutions, specifically addressing the post-operative and recovery market. Evome aims to enhance patient outcomes through its portfolio of devices utilized in rehabilitation settings.

Recent filings

Filing Released Lang Actions
Other.pdf
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the U.S. SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It reports a change in the company's fiscal year end and the termination of a debenture offering. The document includes a press release as an exhibit. The content is an announcement of corporate events and regulatory disclosures rather than a full financial report or earnings release. The Form 8-K is a regulatory filing used to report material events promptly. Therefore, this document fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other specific categories.
2023-04-26 English
News release - English.pdf
Annual Report Classification · 95% confidence The document is a detailed announcement from Salona Global regarding the closing of an acquisition, posting of audited year-end financial statements, and financial highlights for a transition period ending December 31, 2022. It includes comprehensive financial data such as revenue growth, gross margins, EBITDA, and detailed reconciliations of non-GAAP measures. The document also references the filing of an Annual Report on Form 10-KT (Transition) with the SEC and provides extensive financial statements and management discussion. The length of the document (15,000 characters) and the inclusion of substantive financial data and analysis indicate this is a full financial report rather than a brief announcement or summary. The presence of audited year-end financial statements and the reference to a 10-KT filing strongly support classification as an Annual Report. Therefore, the document fits the definition of an Annual Report (10-K). FY 2022
2023-04-03 English
Annual MD&A - English.pdf
Annual Report Classification · 100% confidence The document is a Form 10-KT filed with the United States SEC, which is a transition report pursuant to the Securities Exchange Act of 1934. It covers a transition period from March 1, 2022, to December 31, 2022, and includes detailed sections such as Business Overview, Risk Factors, Management's Discussion and Analysis, Financial Statements, and other typical components of an annual report. The presence of financial data, management discussion, and comprehensive company information confirms it is a full annual report rather than an announcement or certification. Therefore, the document fits the definition of an Annual Report (10-K). FY 2022
2023-04-03 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification by the Chief Financial Officer regarding the accuracy and completeness of an Annual Report on Form 10-KT. It contains attestations about the financial statements and internal controls but does not include actual financial data or the full report itself. The document length is 3409 characters, which is relatively short and consistent with a certification rather than a full report. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than the Annual Report (10-K) itself.
2023-04-03 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification statement by the CEO regarding the accuracy and completeness of an Annual Report on Form 10-KT. It explicitly states it is a certification related to the 10-KT report, focusing on internal controls and financial reporting. The document length is 3369 characters, which is relatively short and primarily contains certification language without substantive financial data or the full report content. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than the Annual Report (10-K) itself, since it does not contain the full report or financial statements but only the certification of the report.
2023-04-03 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 13-502F1 related to participation fees for Class 1 and Class 3B reporting issuers submitted to the Ontario Securities Commission. It includes management certification by the CFO, market value calculations of equity securities, and fee calculations. The content is regulatory in nature, focused on fee reporting and certification rather than financial performance or detailed financial statements. It does not contain an annual report, earnings release, or other financial report types. The document is primarily a regulatory filing with certification and fee calculation details, fitting best under Regulatory Filings (RNS).
2023-04-03 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.